All Pharma News
Phase 3 Data at AAD 2023 Show Deuruxolitinib Improved Scalp Hair Regrowth

Phase 3 Data at AAD 2023 Show Deuruxolitinib Improved Scalp Hair Regrowth
PR NEWSWIRE
18 Mar 2023
Share Share
Sun Pharma Completes Acquisition of Concert Pharmaceuticals

Sun Pharma Completes Acquisition of Concert Pharmaceuticals
PR NEWSWIRE
07 Mar 2023
Share Share
Concert Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA

Concert Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA
BUSINESSWIRE
15 Feb 2023
Share Share
Concert persuades FDA to keep alopecia therapy breakthrough tag

Concert persuades FDA to keep alopecia therapy breakthrough tag
James Waldron FIERCE BIOTECH
15 Feb 2023
Share Share
India`s Sun Pharma acquires U.S. based Concert for $576 mln

India`s Sun Pharma acquires U.S. based Concert for $576 mln
REUTERS
20 Jan 2023
Share Share
Concert Announces Presentation of Deuruxolitinib THRIVE-AA1 PIII Study Results

Concert Announces Presentation of Deuruxolitinib THRIVE-AA1 PIII Study Results
BUSINESSWIRE
21 Nov 2022
Share Share
Concert to Participate in Fireside Chat at the Jefferies London Conference

Concert to Participate in Fireside Chat at the Jefferies London Conference
BUSINESSWIRE
09 Nov 2022
Share Share
Concert Pharmaceuticals Reports Third Quarter 2022 Financial Results

Concert Pharmaceuticals Reports Third Quarter 2022 Financial Results
BUSINESSWIRE
07 Nov 2022
Share Share
Concert Pharmaceuticals to Report Third Quarter 2022 Results on November 7, 2022

Concert Pharmaceuticals to Report Third Quarter 2022 Results on November 7, 2022
BUSINESSWIRE
31 Oct 2022
Share Share
Concert Pharmaceuticals Announces Presentation of CTP-543 THRIVE-AA1 PIII Data

Concert Pharmaceuticals Announces Presentation of CTP-543 THRIVE-AA1 PIII Data
BUSINESSWIRE
10 Sep 2022
Share Share